Acta Med. 2003, 46: 125-127
https://doi.org/10.14712/18059694.2019.20
Infective Endocarditis Caused by Group G Streptococcus with Multiple Cerebral Emboli
References
1. Clin Infect Dis 1998; 26(1):66–71.
< LM. Infective endocarditis caused by beta hemolytic streptococci. Infectious Diseases Society of America’s Emerging Infection Network. https://doi.org/10.1086/516266>
2. Bayer AS, Scheld WM. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R (eds) : Principles and practice of infectious diseases, 5th ed. Philadelphia: Churchill Livingstone Inc., 2000;857–903.
3. Am J Med Sci 1978; 276:269–75.
< DC, Martin DB. Beta hemolytic streptococcal endocarditis: predominance of nongroup A organisms. https://doi.org/10.1097/00000441-197811000-00003>
4. Eur J Clin Microbiol Infect Dis 1990; 4:251–56.
< A, Gaustad P. Septicemia and endocarditis caused by Group G Streptococci in Norwegian Hospital. https://doi.org/10.1007/BF01968055>
5. Am J Med 1994; 96:200–9.
< DT, Lukes AS, Bright DK. Duke Endocarditis Service.New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. https://doi.org/10.1016/0002-9343(94)90143-0>
6. Infect Dis Clin North Am 1993; 17:97–115.
PB. Ceftriaxone and outpatient treatment of infective endocarditis.
7. Euro Heart J 1995; 16(Suppl. B):75–9.
< PB. Antibiotic treatment of streptococcal and enterococcal endocarditis: an overview. https://doi.org/10.1093/eurheartj/16.suppl_B.75>
8. Francioli PB. Complications of infective endocarditis. In: Scheld MW, Whitley RJ, Durack DT (eds): Infections of the central nervous system, 2nd ed. Philadelphia: Lippincott – Raven publishers, 1997:523–55.
9. Am J Med 1983; 75:561–70.
< K, Bayer AS. Serious infections due to Group G Streptococci. Report of 15 cases with in vitro – in vivo correlations. https://doi.org/10.1016/0002-9343(83)90434-5>
10. Clin Infect Dis 2000; 4:633–9.
< JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke Criteria for the diagnosis of infective endocarditis. https://doi.org/10.1086/313753>
11. Moreillon P. Endocarditis and endarteritis. In: Armstrong D, Cohen J (eds): Infectious Disease, 1st ed., Harcourt Publishers Ltd., 1999:2:50.1–10.
12. Am J Med 1987; 82:187–8.
< VIK. Group G streptococcal endocarditis and bacteremia. https://doi.org/10.1016/0002-9343(87)90415-3>
13. Clin Infect Dis 1996; 22:276–86.
< RM, Shafran SD. Infective endocarditis: Review of 135 cases over 9 years. https://doi.org/10.1093/clinids/22.2.276>
14. Clin Infect Dis 1998; 27:1470–4.
< DJ, Tenenbaum MJ, Wilson WR et al. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin susceptible streptococci. https://doi.org/10.1086/515038>
15. J Antimicrob Chemothe 1998; 42: 292–6.
< DC. New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. https://doi.org/10.1093/jac/42.3.292>
16. J Infect 1988; 16:169–76.
< EG, Pallett AP, Davidson RN. Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. https://doi.org/10.1016/S0163-4453(88)94022-4>
17. Chemother 1997; 43:10–20.
< WH, Leonhard B. Comparative susceptibility of clinical group A,B,C,F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. https://doi.org/10.1159/000239529>
18. Arch Intern Med 1985; 145:58–61.
< KL, Kollisch N, Densen P. Group G Streptococcal Bacteremia. The clinical experience at Boston University Medical Center and a critical review of the literature. https://doi.org/10.1001/archinte.1985.00360010078011>